TVTX icon

Travere Therapeutics
TVTX

Overview Fund Activity

209 hedge funds and large institutions have $1.49B invested in Travere Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 76 increasing their positions, 69 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
209
Holders Change
-8
Holders Change %
-3.69%
% of All Funds
2.8%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
40
Increased
76
Reduced
69
Closed
47
Calls
$32.5M
Puts
$7.43M
Net Calls
+$25M
Net Calls Change
+$6.94M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$29.8M
2
FLSM
Frazier Life Sciences Management
California
+$14.8M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.5M
4
PA
Perceptive Advisors
New York
+$12.3M
5
Marshall Wace
Marshall Wace
United Kingdom
+$11M

Top Sellers

1
DCM
Driehaus Capital Management
Illinois
-$49.6M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$46.6M
3
RSCM
Rock Springs Capital Management
Maryland
-$15M
4
WP
Woodline Partners
California
-$10.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$8.63M
Name Holding Trade Value Shares
Change 		Shares
Change %
PWMG
251
Private Wealth Management Group
New Jersey
– -$932 -52 Closed
WA
252
WPG Advisers
Maryland
– -$753 -42 Closed
SW
253
SVB Wealth
Massachusetts
– -$645 -36 Closed
SC
254
Stephens Consulting
Michigan
– -$359 -20 Closed
WA
255
Whipplewood Advisors
Colorado
– -$627 -3 Closed
7 8 9 10
11